Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00187902 · ClinicalTrials.gov registry record
Evaluation of NAATs for Detection of C. Trachomatis and N. Gonorrhoeae From Pharynx, Rectum, Glans & Urethra of MSM
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 907
- Enrollment target
NCT00187902: Completed study, sponsored by University of California, San Francisco.
NCT00187902 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 907 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00187902 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 907 participants
- Enrollment target
Study Summary
Julius Schachter, PhD, from the Department of Laboratory Medicine at UCSF, and Jeffrey Klausner, MD, from the Department of Public Health, are conducting a study to evaluate a type of test (nucleic acid amplification test) for the detection of two sexually transmitted diseases, Chlamydia trachomatis and Neisseria gonorrhoeae, in men who have sex with men (MSM), using urine samples and swabs taken from the throat (pharynx), tip of penis (glans), and rectum. The use of nucleic acid amplification tests on these swabs is experimental, which means that the use of the tests for this purpose have not been approved by the Food \& Drug Administration.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 907 participants |
| Start Date | 2005-10 |
| Est. Completion | 2008-12 |
What the finished NCT00187902 record still lists
NCT00187902 is an observational study that tracks outcomes without assigning an intervention. The registered 907 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00187902 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00187902 about?
NCT00187902 is a clinical study titled "Evaluation of NAATs for Detection of C. Trachomatis and N. Gonorrhoeae From Pharynx, Rectum, Glans & Urethra of MSM". Julius Schachter, PhD, from the Department of Laboratory Medicine at UCSF, and Jeffrey Klausner, MD, from the Department of Public Health, are conducting a study to evaluate a type of test (nucleic acid amplification test) for the detection of two sexually transmitted diseases, Chlamydia trachomatis...
What is the current status of trial NCT00187902?
This trial is currently completed. The enrollment target is 907 participants. The study started on 2005-10. Estimated completion is 2008-12.
Who is sponsoring clinical trial NCT00187902?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05658497 · 908 participants
Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
- NCT06216548 · 909 participants · NA
E-PRIME For Children With Medical Complexity
- NCT05769777 · 901 participants · Phase 2
Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
- NCT06131840 · 914 participants · Phase 1
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia